Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Calculi | 7 | 2015 | 345 | 1.210 |
Why?
|
| Calcium Oxalate | 4 | 2015 | 188 | 0.630 |
Why?
|
| Calcium Phosphates | 3 | 2015 | 84 | 0.630 |
Why?
|
| Hypercalciuria | 3 | 2015 | 47 | 0.600 |
Why?
|
| Dissection | 5 | 2012 | 45 | 0.500 |
Why?
|
| Esophagoscopy | 3 | 2012 | 91 | 0.450 |
Why?
|
| Gastrointestinal Hemorrhage | 6 | 2012 | 246 | 0.430 |
Why?
|
| Esophageal Neoplasms | 3 | 2012 | 345 | 0.430 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2015 | 60 | 0.420 |
Why?
|
| Kidney Tubules | 2 | 2015 | 91 | 0.410 |
Why?
|
| Surgical Instruments | 2 | 2011 | 63 | 0.380 |
Why?
|
| Calcium | 4 | 2015 | 1205 | 0.380 |
Why?
|
| Insufflation | 1 | 2012 | 10 | 0.370 |
Why?
|
| Air | 1 | 2012 | 63 | 0.370 |
Why?
|
| Stomach Diseases | 1 | 2011 | 19 | 0.360 |
Why?
|
| Hamartoma | 1 | 2011 | 33 | 0.350 |
Why?
|
| Hemostasis, Endoscopic | 4 | 2012 | 16 | 0.350 |
Why?
|
| Carbon Dioxide | 1 | 2012 | 212 | 0.340 |
Why?
|
| Endoscopy, Digestive System | 1 | 2009 | 72 | 0.300 |
Why?
|
| Colonoscopy | 4 | 2012 | 304 | 0.300 |
Why?
|
| Gastrointestinal Tract | 1 | 2009 | 197 | 0.270 |
Why?
|
| Diverticulum, Colon | 3 | 2012 | 10 | 0.270 |
Why?
|
| X-Ray Microtomography | 2 | 2014 | 101 | 0.260 |
Why?
|
| Parathyroid Hormone | 2 | 2015 | 228 | 0.230 |
Why?
|
| Nephrocalcinosis | 1 | 2015 | 9 | 0.230 |
Why?
|
| Renal Reabsorption | 1 | 2015 | 7 | 0.230 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2015 | 30 | 0.230 |
Why?
|
| Kidney Tubules, Distal | 1 | 2015 | 19 | 0.230 |
Why?
|
| Medullary Sponge Kidney | 1 | 2015 | 6 | 0.230 |
Why?
|
| Renal Elimination | 1 | 2015 | 8 | 0.220 |
Why?
|
| Lithotripsy | 1 | 2015 | 45 | 0.220 |
Why?
|
| Nephrolithiasis | 1 | 2015 | 25 | 0.220 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2015 | 71 | 0.210 |
Why?
|
| Kidney Medulla | 1 | 2014 | 79 | 0.210 |
Why?
|
| Durapatite | 1 | 2014 | 36 | 0.210 |
Why?
|
| Vitamin D Deficiency | 1 | 2015 | 107 | 0.210 |
Why?
|
| Hyperoxaluria, Primary | 1 | 2013 | 4 | 0.210 |
Why?
|
| Oxalates | 1 | 2013 | 49 | 0.200 |
Why?
|
| Thiazides | 1 | 2013 | 16 | 0.200 |
Why?
|
| Chlorthalidone | 1 | 2013 | 18 | 0.200 |
Why?
|
| Parathyroid Glands | 1 | 2013 | 75 | 0.200 |
Why?
|
| Osteogenesis | 1 | 2015 | 277 | 0.190 |
Why?
|
| Middle Aged | 21 | 2015 | 28207 | 0.190 |
Why?
|
| Diuretics | 1 | 2013 | 77 | 0.190 |
Why?
|
| Vitamin D | 1 | 2015 | 273 | 0.190 |
Why?
|
| Aged | 17 | 2015 | 20848 | 0.180 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 258 | 0.170 |
Why?
|
| Gastroscopy | 2 | 2011 | 25 | 0.170 |
Why?
|
| Adult | 13 | 2015 | 28582 | 0.160 |
Why?
|
| Female | 21 | 2015 | 49872 | 0.160 |
Why?
|
| Carcinoid Tumor | 2 | 2011 | 45 | 0.160 |
Why?
|
| Male | 22 | 2015 | 45686 | 0.160 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2011 | 161 | 0.150 |
Why?
|
| Humans | 28 | 2015 | 95803 | 0.150 |
Why?
|
| Esophagectomy | 2 | 2010 | 92 | 0.150 |
Why?
|
| Stomach Neoplasms | 2 | 2011 | 310 | 0.130 |
Why?
|
| Time Factors | 5 | 2015 | 5561 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2013 | 1463 | 0.110 |
Why?
|
| Aged, 80 and over | 6 | 2012 | 7215 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2773 | 0.110 |
Why?
|
| Japan | 2 | 2012 | 313 | 0.110 |
Why?
|
| Postprandial Period | 2 | 2015 | 48 | 0.110 |
Why?
|
| Gastric Mucosa | 2 | 2011 | 70 | 0.100 |
Why?
|
| Fasting | 2 | 2015 | 165 | 0.100 |
Why?
|
| Epirubicin | 1 | 2013 | 14 | 0.100 |
Why?
|
| Retrospective Studies | 9 | 2013 | 10274 | 0.100 |
Why?
|
| Colon, Ascending | 1 | 2012 | 1 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2010 | 1087 | 0.100 |
Why?
|
| Catheterization, Peripheral | 1 | 2013 | 64 | 0.090 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 113 | 0.090 |
Why?
|
| Meperidine | 1 | 2012 | 11 | 0.090 |
Why?
|
| Midazolam | 1 | 2012 | 49 | 0.090 |
Why?
|
| Colonic Diseases | 1 | 2012 | 61 | 0.090 |
Why?
|
| Conscious Sedation | 1 | 2012 | 78 | 0.090 |
Why?
|
| Jejunal Diseases | 1 | 2011 | 10 | 0.090 |
Why?
|
| Double-Balloon Enteroscopy | 1 | 2011 | 11 | 0.090 |
Why?
|
| Treatment Outcome | 7 | 2013 | 9167 | 0.090 |
Why?
|
| Diverticulosis, Colonic | 1 | 2011 | 2 | 0.090 |
Why?
|
| Ligation | 4 | 2011 | 53 | 0.090 |
Why?
|
| Intestinal Mucosa | 3 | 2011 | 825 | 0.080 |
Why?
|
| Diverticulum | 1 | 2011 | 45 | 0.080 |
Why?
|
| Hypnotics and Sedatives | 1 | 2012 | 142 | 0.080 |
Why?
|
| Postoperative Hemorrhage | 1 | 2011 | 50 | 0.080 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2011 | 114 | 0.080 |
Why?
|
| Colonoscopes | 1 | 2010 | 13 | 0.080 |
Why?
|
| Biopsy | 2 | 2015 | 1208 | 0.080 |
Why?
|
| Cecal Neoplasms | 1 | 2010 | 5 | 0.080 |
Why?
|
| Endoscopes, Gastrointestinal | 1 | 2010 | 8 | 0.080 |
Why?
|
| Ileal Neoplasms | 1 | 2010 | 9 | 0.080 |
Why?
|
| Clarithromycin | 1 | 2009 | 7 | 0.080 |
Why?
|
| Helicobacter Infections | 1 | 2009 | 38 | 0.080 |
Why?
|
| Helicobacter pylori | 1 | 2009 | 38 | 0.080 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2010 | 101 | 0.080 |
Why?
|
| Risk Factors | 4 | 2015 | 5961 | 0.070 |
Why?
|
| Endosonography | 1 | 2009 | 101 | 0.070 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2009 | 84 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 426 | 0.070 |
Why?
|
| Constriction, Pathologic | 1 | 2009 | 219 | 0.070 |
Why?
|
| Rectal Neoplasms | 1 | 2009 | 134 | 0.070 |
Why?
|
| Length of Stay | 1 | 2012 | 833 | 0.070 |
Why?
|
| Models, Biological | 2 | 2015 | 1809 | 0.070 |
Why?
|
| Preoperative Care | 1 | 2009 | 417 | 0.070 |
Why?
|
| Analgesics, Opioid | 1 | 2012 | 513 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 790 | 0.060 |
Why?
|
| Postoperative Complications | 4 | 2011 | 2592 | 0.060 |
Why?
|
| Follow-Up Studies | 5 | 2013 | 3904 | 0.060 |
Why?
|
| Ammonium Chloride | 1 | 2015 | 22 | 0.060 |
Why?
|
| Least-Squares Analysis | 1 | 2015 | 50 | 0.060 |
Why?
|
| Bicarbonates | 1 | 2015 | 58 | 0.060 |
Why?
|
| Sus scrofa | 1 | 2015 | 48 | 0.060 |
Why?
|
| Water-Electrolyte Balance | 1 | 2015 | 70 | 0.060 |
Why?
|
| Phosphorus | 1 | 2015 | 119 | 0.050 |
Why?
|
| Nonlinear Dynamics | 1 | 2015 | 74 | 0.050 |
Why?
|
| Magnesium | 1 | 2015 | 178 | 0.050 |
Why?
|
| Urodynamics | 1 | 2015 | 130 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 1192 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2015 | 133 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 1879 | 0.050 |
Why?
|
| Sodium | 1 | 2015 | 340 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2015 | 509 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 847 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 1 | 2015 | 281 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 138 | 0.050 |
Why?
|
| Linear Models | 1 | 2015 | 438 | 0.050 |
Why?
|
| Hyperoxaluria | 1 | 2013 | 26 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 186 | 0.050 |
Why?
|
| Renal Insufficiency | 1 | 2013 | 99 | 0.050 |
Why?
|
| Calcinosis | 1 | 2014 | 232 | 0.050 |
Why?
|
| Young Adult | 2 | 2015 | 7026 | 0.050 |
Why?
|
| Sex Factors | 1 | 2015 | 1127 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2014 | 323 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2010 | 1069 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2015 | 926 | 0.040 |
Why?
|
| Adolescent | 2 | 2014 | 9873 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1957 | 0.040 |
Why?
|
| Esophagoscopes | 2 | 2010 | 3 | 0.040 |
Why?
|
| Esophageal Stenosis | 2 | 2010 | 25 | 0.040 |
Why?
|
| Catheterization | 2 | 2010 | 237 | 0.030 |
Why?
|
| Insulin | 1 | 2013 | 1190 | 0.030 |
Why?
|
| Biomarkers | 1 | 2015 | 1931 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 1096 | 0.030 |
Why?
|
| Prognosis | 1 | 2015 | 3990 | 0.030 |
Why?
|
| Infant | 1 | 2013 | 3360 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 1613 | 0.030 |
Why?
|
| Algorithms | 1 | 2015 | 2015 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2013 | 3970 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2013 | 3106 | 0.030 |
Why?
|
| Age Factors | 2 | 2010 | 1957 | 0.030 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2013 | 41 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2012 | 297 | 0.020 |
Why?
|
| United States | 1 | 2015 | 7765 | 0.020 |
Why?
|
| Epinephrine | 1 | 2011 | 92 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2011 | 68 | 0.020 |
Why?
|
| Embolization, Therapeutic | 1 | 2013 | 279 | 0.020 |
Why?
|
| Amoxicillin | 1 | 2009 | 12 | 0.020 |
Why?
|
| Minocycline | 1 | 2009 | 15 | 0.020 |
Why?
|
| Pressure | 1 | 2010 | 175 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 311 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 883 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 1971 | 0.020 |
Why?
|
| Equipment Design | 1 | 2010 | 427 | 0.020 |
Why?
|
| Water | 1 | 2010 | 307 | 0.020 |
Why?
|
| Colectomy | 1 | 2009 | 192 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 1211 | 0.020 |
Why?
|
| Reoperation | 1 | 2011 | 707 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2010 | 463 | 0.020 |
Why?
|
| Animals | 1 | 2015 | 28888 | 0.010 |
Why?
|